Deal Library / Pharma BD Deal Intelligence

Ipsen S.A. — Pharma Deals

The Pharma Closeout tracks 6 deals, $5.5B in disclosed deal value, 3 with a post-close Outcome Score for Ipsen S.A..

Median Critic Score: 51  ·  Median Outcome Score: 68

Best outcome: Ipsen S.A. / Exelixis Inc. (80)  ·  Weakest outcome: Ipsen S.A. / Memo Therapeutics AG (66)

All 6 deals

• Ipsen S.A. / Exelixis Inc. — 2016 · $855M · Worked — the deal delivered on its rationale.
• Ipsen S.A. / Kartos Therapeutics, Inc. — 2026 · $1.8B · Largely worked — most objectives met.
• Ipsen S.A. / Memo Therapeutics AG — 2026 · $797M · Largely worked — most objectives met.
• Ipsen S.A. / Epizyme Inc. — 2022 · $247M
• Ipsen S.A. / GENFIT — 2021 · $543M
• Ipsen S.A. / Clementia Pharmaceuticals Inc. — 2019 · $1.3B

← Deal Library  ·  Interactive search  ·  How we score deals